To learn more information about Nova Southeastern University College of Pharmacy or to apply now, use one of the options below.
Program Information -- Select Program -- Pharm.D. Entry-Level Pharm.D. Advanced Standing Pharm.D. Concurrent Degrees M.S. Pharmaceutical Affairs M.S. Pharmaceutical Sciences Ph.D. Pharmaceutical Sciences Application Link -- Select Program -- Pharm.D. Entry Level Pharm.D. Advanced Standing M.S. Pharmaceutical Affairs M.S. Pharmaceutical Sciences Ph.D. Pharmaceutical Sciences Non-Degree
Research Interests: Molecular pharmacology, physiology and biology of G protein-coupled (heptahelical or seven transmembrane-spanning) receptors; Heart Failure; Cardiovascular Disease; Neurohormonal control of the Circulation; Adrenal Physiology and Pharmacology; Receptors for Adrenaline and Noradrenaline; Catecholamines; Receptors for Angiotensin II; Signal Transduction; Gene Therapy; Transgenic mice and rats; Aldosterone production regulation; Regulation of Adrenergic and Angiotensin Receptors; G protein-coupled receptor Kinases; Beta-Arrestins; Novel "Biased" G protein-coupled Receptor Ligands.
From left to right: Katie A. McCrink, B.S., Pharm.D. Student; Anastasios Lymperopoulos, Ph.D., FAHA;Ava Brill, B.S., Pharm.D. Student.
From left to right: Christine Marrero, B.S., DO Student; Anastasios Lymperopoulos, Ph.D., FAHA; Thairy Reyes Valero, B.S., DO Student; Malika Jafferjee, B.S., DO Student.
Dr. Lymperopoulos and his research group featured in SharkBytes: "College of Pharmacy and Halmos College Faculty Collaborate in Journal Article"
Dr. Lymperopoulos is also collaborating with the University Federico II in Naples, Italy (Dr. Rengo`s & Dr. Leosco`s groups), Temple University in Philadelphia, PA (Dr. Koch`s group), the University of Florida in Gainesville, FL (Dr. Sumner`s group), and the University of Miami Miller School of Medicine (Dr. Hare`s group).
Provisional Patent Application entitled: “Methods and Compositions for Treatment of Heart Failure”. Application #: 62128335. Inventors: Lymperopoulos, A.
Contact: Tassos (Anastasios) Lymperopoulos,